The article discusses whether young people without cholesterol problems should take statins, which are cholesterol-lowering drugs. The decision by the U.S. National Heart, Lung, and Blood Institute’s National Cholesterol Education Program (NCEP) to release guidelines that recommend statins for people without prior cholesterol issues is considered controversial. Topics include a brief overview of NCEP’s 2004 guidelines for prescribing statins for heart disease patients with high levels of low density lipoproteins (LDL) levels, the theory that the 2010 guidelines will help prevent cardiovascular disease later in life, and clinical trials providing direct evidence for the benefits of statins as primary prevention.
© 2001-2026 Fundación Dialnet · Todos los derechos reservados